Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer
Condition(s):Metastatic Colorectal CancerLast Updated:April 27, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Metastatic Colorectal CancerLast Updated:April 27, 2017Unknown status
Condition(s):Hepatocellular CarcinomaLast Updated:June 24, 2020Unknown status
Condition(s):Biliary Tract Cancer; Anti-PD-1 Therapy; Targeted Molecular Therapy; CapecitabineLast Updated:January 30, 2024Completed
Condition(s):Gastric CancerLast Updated:July 26, 2018Unknown status
Condition(s):Gastric CarcinomaLast Updated:November 28, 2017Not yet recruiting
Condition(s):Advanced Gastric AdenocarcinomaLast Updated:February 2, 2024Completed
Condition(s):Triple-negative Breast CancerLast Updated:December 14, 2018Unknown status
Condition(s):Stomach Neoplasms; Gastrointestinal Neoplasms; Stomach Diseases; Digestive System Neoplasms; Capecitabine; Apatinib; Neoplasms; Molecular Mechanisms of Pharmacological ActionLast Updated:March 26, 2019Unknown status
Condition(s):Colorectal NeoplasmsLast Updated:July 12, 2016Unknown status
Condition(s):Biliary CarcinomaLast Updated:August 9, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.